Next-generation sequencing-aided precise diagnosis of Stickler syndrome type I.

Wang DD1,2,3, Gao FJ1,2,3, Hu FY1,2,3, Li JK4, Zhang SH1,2,3, Xu P1,2,3, Chang Q1,2,3, Jiang R1,2,3, Wu JH1,2,3.

Author information

1: Eye Institute, Eye and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
2: Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shanghai, China.
3: Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences, National Health Commission, Shanghai, China.
4: BGI-Shenzhen, Shenzhen, China.

Abstract

PURPOSE:

To explore an early, rapid and precise diagnosis of Stickler syndrome type I (STL1) and to enrich the spectrum of COL2A1 mutations in the Chinese population, which is poorly studied at present.

METHODS:

In the current study, we analysed 115 patients with high myopia by next-generation sequencing and identified five STL1 patients from four unrelated Chinese families. The clinical features of all patients were reviewed in detail.

RESULTS:

Four variants of COL2A1 were identified, including two novel variants (c.1435delG and c.184delG) and two previously reported variants (c.1221+1G>A and c.1030C>T). Three variants caused premature termination codons which were common in STL1. In addition, we proposed a new diagnostic tactic to improve early diagnostics of STL1 in patients.

CONCLUSION:

In this study, our findings expanded the spectrum of COL2A1 mutations with two novel variants and provided a new diagnostic tactic for reference, which was of great significance. Precise diagnosis on the basis of clinical manifestations and genetic testing will become the gold standard to diagnose inherited ocular disorders or syndromes in the future.